ロード中...
Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
Molecular characterization is currently a key step in NSCLC therapy selection. Circulating tumor cells (CTC) are excellent candidates for downstream analysis, but technology is still lagging behind. In this work, we show that the mutational status of NSCLC can be assessed on hypermetabolic CTC, dete...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6115779/ https://ncbi.nlm.nih.gov/pubmed/30110953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10080270 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|